ALEXANDRIA, Va., June 12 -- United States Patent no. 12,295,988, issued on May 13, was assigned to Novo Nordisk A/S (Bagsvaerd, Denmark).
"Semaglutide in medical therapy" was invented by Lars Holm Damgaard (Herlev, Denmark), Soeren Oestergaard Hardt-Lindberg (Virum, Denmark) and Thomas Hansen (Broenshoej, Denmark).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to semaglutide for use in weight management."
The patent was filed on Aug. 30, 2024, under Application No. 18/820,792.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=A...